| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | - | 198.822 | 211.943 | 157.946 | 191.749 | - | - | - |
| Total Income - EUR | - | 0 | - | 198.822 | 211.943 | 159.608 | 192.212 | - | - | - |
| Total Expenses - EUR | - | 0 | - | 192.365 | 205.522 | 173.440 | 175.155 | - | - | - |
| Gross Profit/Loss - EUR | - | 0 | - | 6.457 | 6.421 | -13.833 | 17.057 | - | - | - |
| Net Profit/Loss - EUR | - | 0 | - | 4.469 | 4.297 | -15.414 | 15.139 | - | - | - |
| Employees | - | 0 | - | 4 | 4 | 3 | 4 | - | - | - |
Check the financial reports for the company - Novasens Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | - | 4.027 | 3.280 | 2.250 | 1.253 | - | - | - |
| Current Assets | - | 0 | - | 22.167 | 22.656 | 22.816 | 47.705 | - | - | - |
| Inventories | - | 0 | - | 10.211 | 6.123 | 9.306 | 21.536 | - | - | - |
| Receivables | - | 0 | - | 15 | 3.118 | 476 | 515 | - | - | - |
| Cash | - | 0 | - | 11.941 | 13.415 | 13.035 | 25.654 | - | - | - |
| Shareholders Funds | - | 0 | - | 4.079 | 4.402 | -11.096 | 19.362 | - | - | - |
| Social Capital | - | 0 | - | 43 | 42 | 41 | 40 | - | - | - |
| Debts | - | 0 | - | 22.116 | 21.534 | 36.162 | 29.596 | - | - | - |
| Income in Advance | - | 0 | - | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4719 - 4719" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Novasens Med Srl